Press Release

Ophthalmic Devices Market Size Worth USD 95.4 Billion by 2030 | CAGR of 5.1% Report

Date : Jul 19, 2023

The global Ophthalmic Devices Market has been experiencing steady expansion over the last few years, driven by rising prevalence of eye diseases, continuous technological advancements in diagnostics and surgical devices, increasing demand for vision correction solutions, and growing awareness regarding eye health. Ophthalmic devices are vital for diagnosis, monitoring, screening and treatment of various eye disorders including cataract, glaucoma, diabetic retinopathy, age-related macular degeneration, astigmatism, myopia, and presbyopia among others. This article offers a detailed analysis of the ophthalmic devices market covering key statistics, market overview, current trends and developments, major factors propelling market growth, key challenges, market segmentation analysis, regional markets outlook, and profiles of leading market players.

Market Statistics and Highlights:

·         The global ophthalmic devices market was valued at USD 61.2 billion in 2021. It is projected to expand at a CAGR of 5.1% between 2022 and 2030 to reach USD 95.4 billion by 2030.

·         The vision care segment held the dominant share in 2021, while the surgical devices segment is slated to grow at the highest CAGR during the forecast period.

·         Rising geriatric populations susceptible to age-related eye diseases, advancements in diagnostic technologies such as Optical Coherence Tomography (OCT), increase in regulatory approvals for innovative ophthalmic devices, and surging demand for minimally invasive sight restoration surgeries are major factors driving ophthalmic devices market growth.

Request for a sample of this premium research report @ https://www.amecoresearch.com/sample/276879

Comprehensive Market Overview and Analysis:

The ophthalmic devices market has been expanding at a steady pace globally, majorly driven by the rising prevalence of eye disorders such as cataract, glaucoma, diabetic retinopathy, presbyopia, astigmatism etc. in the growing aging demographic. According to WHO, around 2.2 billion people suffer from vision impairment or blindness worldwide. Cataracts account for over 50% of global cases of blindness. The market has witnessed many technological advancements and key innovations in recent years, including the introduction of combined diagnostic-surgical systems, advanced Intraocular Lenses (IOLs) with aspheric, toric and multifocal lens designs, and Artificial Intelligence (AI) integrated retinal imaging systems for enhanced early disease diagnosis and screening.

The demand for minimally invasive ophthalmic surgeries utilizing laser and microincision techniques has also surged significantly owing to associated advantages like quicker recovery times, lesser postoperative complications and patient discomfort. However, the high costs of advanced ophthalmic devices coupled with low accessibility in developing countries are major factors hampering growth. The dearth of skilled ophthalmologists, especially in rural areas, also restricts market expansion. Nevertheless, underserved areas represent significant untapped growth opportunities.

Current Market Trends and Developments:

·         Rising adoption of bladeless laser cataract surgeries like femtosecond laser-assisted cataract surgery and laser-assisted in situ keratomileusis (LASIK) due to advantages over traditional approaches.

·         Increasing usage of optical coherence tomography (OCT) systems in ophthalmic diagnostics for obtaining high-resolution cross-sectional retinal images.

·         Integration of artificial intelligence and machine learning in diagnostic tools to enable quicker evaluation of test results and early disease detection through retinal imaging.

·         Advancements in intraocular lens (IOL) designs such as aspheric, toric and multifocal lenses to provide better vision correction tailored to patient needs.

·         Growing research on sustained drug delivery implants and injection devices for treatment of chronic eye diseases like glaucoma and age-related macular degeneration.

·         Development of combination products merging diagnostic and drug delivery functions for convenient self-administration and monitoring.

Major Factors Fueling Market Growth:

·         Rising geriatric population: Age-related eye diseases such as cataract, glaucoma, dry eye syndrome, diabetic retinopathy etc. are more prevalent among the elderly. The rapidly aging global population is a major growth driver.

·         Technological advancements in devices leading to early diagnosis, enhanced screening and improved treatment outcomes through precision.

·         Increase in regulatory approvals and launches for advanced ophthalmic devices due to their rising demand globally. This is expanding the product portfolio.

·         High unmet clinical needs and increasing awareness regarding eye disorders are boosting adoption of ophthalmic devices for vision care.

·         Rising investments in R&D activities resulting in innovative product launches using emerging technologies.

·         Surging demand for minimally invasive procedures like LASIK and robotic eye surgeries due to quicker recovery and less complications.

Challenges Restricting Market Expansion:

·         High costs and low accessibility of advanced ophthalmic devices especially in developing regions with resource constraints hampers adoption.

·         Shortage of skilled ophthalmologists and lack of proper eye care infrastructure in rural areas limits access to vision care treatments involving ophthalmic devices.

·         Stringent regulatory policies for product approval and post-marketing surveillance pose hurdles for manufacturers to introduce new ophthalmic devices quickly.

·         Risks of complications and infections associated with ophthalmic implants impacts adoption among some patient groups.

·         Frequent product recalls due to adverse events or manufacturing flaws disrupts revenue streams of ophthalmic device suppliers.

Market Segmentation Analysis:

Market By Product Type

·         Ophthalmic Surgical Devices

o   Refractive Error Surgical Devices

§  Excimers And Femtosecond Lasers

§  Microkeratomes)

o   Glaucoma Surgical Devices

§  Implants And Stents

§  Glaucoma Drainage

§  Glaucoma Laser Devices)

o   Cataract Surgery Devices

§  Intraocular Lenses

§  Viscoelastics

§  Phacoemulsification Systems

o   Vitroretinal Surgical Devices

§  Vitroectomy Machines & Vitroectomy Packs

§  Photocoagulation Lasers

§  Illumination Devices)

·         Ophthalmic Diagnostic Devices

o   Refractors

o   Corneal Topography Systems

o   Retinal Ultrasound Systems

o   Fundus Camera

o   Ophthalmoscopes

o   Optical Coherence Tomography Systems

o   Perimeters

o   Slit Lamps

o   Tonometers)

·         Ophthalmic Vision Care Devices

o   Contact Lenses

o   Spectacle Lenses

Regional Market Analysis:

North America accounted for the largest share of over 35% in the global ophthalmic devices market in 2021, driven by rising incidence of eye diseases, access to advanced eye care facilities, high healthcare spending and faster adoption of new technologies in the region.

Asia Pacific is anticipated to exhibit the fastest growth during the forecast period on account of expanding elderly populations, improvements in healthcare infrastructure, increasing penetration of global ophthalmic device manufacturers in emerging APAC countries, and rising medical tourism for ophthalmic treatments.

Key Companies in the Market:

Johnson & Johnson Vision Care, Alcon (Part of Novartis), Carl Zeiss Meditec AG, Bausch Health Companies, EssilorLuxottica, Hoya Corporation, Topcon Corporation, NIDEK Co. Ltd., Haag-Streit Group, Ziemer Ophthalmic Systems AG, Glaukos Corporation, Staar Surgical Company, Lumenis Ltd., Canon and Danaher.

To receive personalized service, please share your research needs here@ https://www.amecoresearch.com/enquiry-before-buy/276879

Buy this premium research report - https://www.amecoresearch.com/buy/276879

Contact Us:

Mr. Richard    

Ameco Research

USA: +1 347 474 3864

India: +91 8983225533

E-mail: sales@amecoresearch.com